1-5 of 5
Elias J. Jabbour
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Venetoclax plus low intensity chemotherapy for adults with acute lymphoblastic leukemia

Clinical Trials & Observations
Marlise R. Luskin, Shai Shimony, Julia H. Keating, Eric S Winer, Jacqueline S. Garcia, Richard M. Stone, Elias J. Jabbour, Yael Flamand, Kristen Stevenson, Jeremy Adam Ryan, Zhihong Zeng, Anthony Letai, Marina Y. Konopleva, Nitin Jain, Daniel J DeAngelo
Journal: Blood Advances
Blood Adv bloodadvances.2024014405.
https://doi.org/10.1182/bloodadvances.2024014405
Published: 2024
Includes: Supplemental data
Journal Articles

Prognostic risk signature in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax

Clinical Trials & Observations
Alex Bataller, Alexandre Bazinet, Courtney D. DiNardo, Abhishek Maiti, Gautam Borthakur, Naval G. Daver, Nicholas J. Short, Elias J. Jabbour, Ghayas C. Issa, Naveen Pemmaraju, Musa Yilmaz, Guillermo Montalban-Bravo, Koichi Takahashi, Sanam Loghavi, Guillermo Garcia-Manero, Farhad Ravandi, Hagop M. Kantarjian, Tapan M. Kadia
Journal: Blood Advances
Blood Adv (2024) 8 (4): 927–935.
https://doi.org/10.1182/bloodadvances.2023011757
Published: 2024
Includes: Supplemental data
Journal Articles

Impact of type of induction therapy on outcomes in older adults with AML after allogeneic stem cell transplantation

Clinical Trials & Observations
Nicholas J. Short, Faustine Ong, Farhad Ravandi, Graciela Nogueras-Gonzalez, Tapan M. Kadia, Naval Daver, Courtney D. DiNardo, Marina Konopleva, Gautam Borthakur, Betul Oran, Gheath Al-Atrash, Rohtesh Mehta, Elias J. Jabbour, Musa Yilmaz, Ghayas C Issa, Abhishek Maiti, Richard E Champlin, Hagop Kantarjian, Elizabeth J Shpall, Uday Popat
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3573–3581.
https://doi.org/10.1182/bloodadvances.2022009632
Published: 2023
Includes: Supplemental data
Journal Articles

Prognostic value of measurable residual disease after venetoclax and decitabine in acute myeloid leukemia

Clinical Trials & Observations
Abhishek Maiti, Courtney D. DiNardo, Sa A. Wang, Jeffrey Jorgensen, Tapan M. Kadia, Naval G. Daver, Nicholas J. Short, Musa Yilmaz, Naveen Pemmaraju, Gautam Borthakur, Prithviraj Bose, Ghayas C. Issa, Alessandra Ferrajoli, Elias J. Jabbour, Nitin Jain, Guillermo Garcia-Manero, Maro Ohanian, Koichi Takahashi, Guillermo Montalban-Bravo, Lucia Masarova, Jan A. Burger, Philip A. Thompson, Srdan Verstovsek, Koji Sasaki, Michael Andreeff, Caitlin R. Rausch, Kathryn S. Montalbano, Sherry Pierce, Wei Qiao, Jing Ning, Hagop M. Kantarjian, Marina Y. Konopleva, Farhad Ravandi
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1876–1883.
https://doi.org/10.1182/bloodadvances.2020003717
Published: 2021
Includes: Supplemental data
Journal Articles

Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories

Clinical Trials & Observations
Sanam Loghavi, Dawen Sui, Peng Wei, Guillermo Garcia-Manero, Sherry Pierce, Mark J. Routbort, Elias J. Jabbour, Naveen Pemmaraju, Rashmi Kanagal-Shamanna, H. Deniz Gur, Shimin Hu, Zhuang Zuo, L. Jeffrey Medeiros, Hagop M. Kantarjian, Joseph D. Khoury
Journal: Blood Advances
Blood Adv (2018) 2 (15): 1807–1816.
https://doi.org/10.1182/bloodadvances.2018019224
Published: 2018
Includes: Supplemental data